Breast Screening Guideline Debates, Overdiagnosis, and Supplemental MRI Selection
Mammography remains the screening foundation, with MRI for appropriately high-risk women; dense breasts alone do not mandate supplemental imaging. BRAID reported 17–19 additional cancers per 1,000 women with dense breasts after normal mammography using supplemental CEM or MRI, but detection gains do not settle mortality, false-positive, overdiagnosis, access, or cost tradeoffs. Mayo findings on 70 partially functioning BRCA2 variants associated with estimated 20–25% lifetime risk may refine decisions, but validation and clinical guidance are needed.
Sources (18)
Updated Nov 18, 2026